Company Filing History:
Years Active: 2022-2025
Title: Iva Kezic: Innovator in Depression Treatment
Introduction
Iva Kezic is a notable inventor based in Antwerp, Belgium, recognized for his contributions to the field of pharmaceuticals. With a total of eight patents to his name, he has made significant strides in developing treatments for mental health conditions, particularly major depressive disorder.
Latest Patents
Kezic's latest patents focus on innovative compositions and methods for treating depression. One of his key inventions involves the use of aticaprant, a compound aimed at treating major depressive disorder in patients experiencing moderate to severe anhedonia. The methods outlined in his patent include administering an effective amount of aticaprant or its pharmaceutically acceptable salts to patients who have not responded adequately to other antidepressant therapies. This includes treatments involving selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Additionally, he has developed oral compositions, such as tablets, that incorporate aticaprant, further expanding the options available for treating depression.
Career Highlights
Iva Kezic is currently employed at Janssen Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical industry. His work is characterized by a commitment to improving the lives of individuals suffering from mental health disorders through effective treatment options.
Collaborations
Kezic collaborates with talented professionals in his field, including Mark Schmidt and Vanina Popova, who contribute to the development and refinement of his innovative treatments.
Conclusion
Iva Kezic's work in the pharmaceutical industry, particularly in the treatment of depression, showcases his dedication to advancing mental health therapies. His patents reflect a significant contribution to the field, offering hope for improved treatment options for patients worldwide.